Archives
-
G007-LK and the Next Phase of Tankyrase Translation
2026-10-06
Tankyrase biology is moving beyond a single-pathway view of Wnt regulation. This source-grounded analysis examines how G007-LK connects AXIN-dependent β-catenin control with Hippo-YAP signaling, evaluates the preclinical evidence, and outlines translational questions for APC-mutant colorectal cancer and hepatocellular carcinoma research.
-
Luteolin Bioavailability and P-Glycoprotein Efflux
2026-10-06
A 2026 Journal of Advanced Research study developed a luteolin-loaded self-microemulsifying drug delivery system designed to address poor absorption and P-glycoprotein-mediated efflux. The formulation improved cellular uptake and produced a reported 29-fold increase in pharmacokinetic AUC, while the evidence remains preclinical and formulation-specific.
-
EGCG Analogs for Extracellular and Intracellular S. aureus
2026-10-05
Grosso and colleagues developed modified EGCG analogs designed to address the parent compound’s limited stability, membrane permeability, and bioavailability while retaining antistaphylococcal activity. In vitro results identified MCC-1 and MCC-2 as lead candidates that improved activity against extracellular and intracellular Staphylococcus aureus and enhanced β-lactam-associated effects against MRSA, although clinical translation remains un established.
-
Oteseconazole in the 2022 FDA DDI Evidence Review
2026-10-05
A 2024 analysis of FDA New Drug Application reviews mapped enzyme- and transporter-mediated drug-drug interactions across 22 small-molecule drugs approved in 2022. Its inclusion of Oteseconazole (VT-1161) among compounds with P-glycoprotein and/or breast cancer resistance protein inhibition illustrates how regulatory pharmacokinetic evidence can inform concomitant-use decisions without replacing drug-specific clinical assessment.
-
Targeted SPP1 Inhibition in Tumor Myeloid Cells
2026-10-04
The reference study reports a phenotypic small-molecule screen that identified modulators of SPP1 expression in macrophages and paired the lead compound, CANDI460, with a TAM-avid polymeric delivery system. Across cell-based and murine tumor studies, this strategy reduced SPP1-associated myeloid phenotypes and tumor burden, while remaining limited by preclinical models, delivery complexity, and unresolved questions about SPP1 causality.
-
G007-LK: Reading Tankyrase Evidence Clearly
2026-10-03
G007-LK is a tankyrase 1/2 inhibitor with applications spanning Wnt/β-catenin and Hippo pathway research. This evidence-focused guide separates established findings from interpretation, helping researchers assess APC-mutant colorectal cancer and hepatocellular carcinoma models without overextending the data.
-
RNA G-Quadruplexes Modulate TDP-43 Toxicity
2026-10-02
Oldani and colleagues show that RNA G-quadruplexes are active regulators of TDP-43 aggregation, condensation, cellular distribution, and toxicity rather than passive binding partners. By combining reconstituted assays with yeast, HEK293T, and motor-neuron-like cell models, the study identifies G-quadruplex stabilization as a possible strategy for modifying stress-associated TDP-43 pathology, while leaving important questions about structure selectivity and disease relevance unresolved.
-
Light-Controlled RNA Release in Gene Therapy
2026-10-01
A 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that suppresses mRNA translation in darkness and permits transgene expression under blue or ambient light. In mouse models, this reversible switch regulated therapeutic programs for diet-induced obesity and retinal neovascular disease, illustrating how optical control may improve the timing and safety of gene therapy.
-
Budesonide Workflows for Lung Permeability Research
2026-10-01
Build a practical Budesonide workflow that connects biomimetic membrane screening with asthma inflammation model design. The approach uses IAM-LC, OT-CEC, and MS to distinguish membrane partitioning, pulmonary permeability, and downstream airway inflammation effects.
-
Nelfinavir Mesylate: Assay Logic Beyond HIV
2026-09-30
Nelfinavir Mesylate is a potent HIV-1 protease inhibitor with a second research dimension in DDI2-NFE2L1 regulation and ferroptosis sensitivity. This guide shows how to separate antiviral target engagement from proteostasis-driven phenotypes when designing rigorous assays.
-
HRP Goat Anti-Mouse IgG (H+L): K1221
2026-09-30
Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated is a polyclonal Horseradish Peroxidase conjugated secondary antibody for detecting mouse IgG in Western blotting, ELISA, IHC, and ICC. K1221 is supplied at 1 mg/mL and is formulated for refrigerated short-term storage or aliquoted frozen storage according to the product information.
-
Limb Organoids Reveal How AER Signaling Centers Pattern Fate
2026-09-29
The reference study introduces mESC-derived limb organoids, or budoids, that combine AER-like ectoderm, surface ectoderm, and mesodermal populations in a self-organizing system. Its findings indicate that AER-like cells do more than provide local developmental signals: they support neighboring mesodermal and fibroblast identities while coordinating tissue polarization and distant cartilage formation.
-
URB597 (KDS-4103): FAAH Research Workflow
2026-09-29
URB597 enables target-level interrogation of FAAH, anandamide turnover, and endocannabinoid signaling without treating a behavioral phenotype as proof of mechanism. This workflow connects biochemical target engagement with pain, neuroplasticity, and neuroinflammation assays while showing how to use the cannabidiol literature as a comparator rather than a substitute.
-
Simvastatin Induces Autophagy in Prostate Cancer
2026-09-28
Miyazawa and colleagues show that simvastatin suppresses proliferation across several prostate cancer cell lines while increasing autophagy, with the strongest mechanistic evidence obtained through LC3 analysis, autophagosome imaging, and pharmacological perturbation. The study positions autophagy as a testable component of simvastatin activity in castration-resistant prostate cancer models, while also identifying important limits for translating cholesterol biology into oncology.
-
Ionophore Toxicity in Animals: Mechanisms and Evidence
2026-09-28
Ekinci, Chłodowska, and Olejnik review how polyether ionophores used against poultry coccidiosis can cause toxicity, emphasizing the roles of dose, species, age, and disrupted cellular ion balance. Their synthesis connects clinical injury—especially to cardiac and skeletal muscle—with impaired oxidative phosphorylation, while highlighting uncertainties in molecular mechanisms and drug interactions.